DEA to legalize marijuana chemical for Big Pharma but keep it a crime for everyone else

by Mike Adams, the Health Ranger
Editor of NaturalNews.com

(NaturalNews)Have no illusions about the true nature of the so-called "War on Drugs" and the actions of the DEA. The War on Drugs has always been about protecting the profits of the drug companies which have a long and well-documented history of copying street drugs, repackaging them as "medications" and selling them to children as FDA-approved drugs (see below).

Today, yet another example emerges as the DEA moves to legalize THC in Big Pharma's pills while simultaneously making it illegal for anyone else to grow, sell or possess THC. The DEA, you see, is working to change the classification of THC from a schedule I substance (like street heroin) to a schedule III drug (pharmaceuticals). So if Big Pharma grows its own marijuana plants, extracts the THC and puts it into a "pot pill," those pills will be perfectly legal. They're already FDA approved, actually, when made with the synthetic version of THC.

But if a guy grows the very same chemical in his backyard, then extracts THC from those plants -- even for his own personal use -- suddenly he's guilty of committing a federal crime and will likely be subjected to an armed raid by DEA agents.

The DEA answers to its pharma slave masters

Why would the DEA decide to legalize THC only for pharmaceutical companies? Well, because Big Pharma requested it, of course! As the DEA says on the subject:

"The DEA has received four petitions from companies that have products that are currently the subject of ANDAs (abbreviated new drug applications) under review by the FDA. ...While the petitioners cite that their generic products are bioequivalent to Marinol, their products do not meet schedule III current definition provided above. Therefore, these firms have requested that 21 CFR 1308.13(g)(1) be expanded to include naturally derived or synthetically produced dronabinol."

You can read it all at the DEA's own website: http://www.deadiversion.usdoj.gov/f...

The DEA goes on to say:

"This proposed action expands the schedule III listing to include formulations having naturally-derived dronabinol and products encapsulated in hard gelatin capsules. This would have the effect of transferring the FDA-approved versions of such generic Marinol[supreg] products from schedule I to schedule III."

Read the article